Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer

NCT04593381 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
376
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gemelli Molise Hospital

Collaborators